CIK 0000876343
- Non-accelerated filer
- Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 943127919
- Phone
- +1 510-521-3390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $4.05 ($40,490)
- 4 Exercise or conversion Chief Executive Officer acquired 20,000 shares (option exercise)
- 4 Open-market buy Director bought 5,000 shares at $4.17 ($20,850)
- 4 Open-market buy Director bought 6,250 shares at $3.98 ($24,850)
- 4 Open-market buy Director bought 10,000 shares at $4.12 ($41,200)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at an average $4.68 ($23,379)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Financial Officer bought 2,000 shares at $4.17 ($8,340)
- 4 Exercise or conversion Vice President & Secretary acquired 80,000 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 19 of 37 · 722 filings